Brief: Finch Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
31/03/2022 22:05
March 31 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
* FINCH THERAPEUTICS GROUP INC - CASH AND CASH EQUIVALENTS
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL EXPENDITURES
INTO MID-2023
* FINCH THERAPEUTICS GROUP INC - QTRLY LOSS PER SHARE $0.40
Source text for Eikon: ID:nGNX5Sm1Yx
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp